[go: up one dir, main page]

FR2818551B1 - Utilisation de chelateurs pour le traitement des maladies a prions - Google Patents

Utilisation de chelateurs pour le traitement des maladies a prions

Info

Publication number
FR2818551B1
FR2818551B1 FR0015571A FR0015571A FR2818551B1 FR 2818551 B1 FR2818551 B1 FR 2818551B1 FR 0015571 A FR0015571 A FR 0015571A FR 0015571 A FR0015571 A FR 0015571A FR 2818551 B1 FR2818551 B1 FR 2818551B1
Authority
FR
France
Prior art keywords
chelators
treatment
prion diseases
prion
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0015571A
Other languages
English (en)
Other versions
FR2818551A1 (fr
Inventor
Claude Marc Pierre Hannoun
Michel Xilinas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR0015571A priority Critical patent/FR2818551B1/fr
Priority to PCT/IB2001/002572 priority patent/WO2002051415A2/fr
Priority to AU2002216305A priority patent/AU2002216305A1/en
Publication of FR2818551A1 publication Critical patent/FR2818551A1/fr
Application granted granted Critical
Publication of FR2818551B1 publication Critical patent/FR2818551B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0015571A 2000-12-22 2000-12-22 Utilisation de chelateurs pour le traitement des maladies a prions Expired - Fee Related FR2818551B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0015571A FR2818551B1 (fr) 2000-12-22 2000-12-22 Utilisation de chelateurs pour le traitement des maladies a prions
PCT/IB2001/002572 WO2002051415A2 (fr) 2000-12-22 2001-12-17 Utilisation de chelateurs dans le traitement des maladies a prions
AU2002216305A AU2002216305A1 (en) 2000-12-22 2001-12-17 Use of sequestrants for treating prion diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0015571A FR2818551B1 (fr) 2000-12-22 2000-12-22 Utilisation de chelateurs pour le traitement des maladies a prions

Publications (2)

Publication Number Publication Date
FR2818551A1 FR2818551A1 (fr) 2002-06-28
FR2818551B1 true FR2818551B1 (fr) 2007-06-01

Family

ID=8857123

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0015571A Expired - Fee Related FR2818551B1 (fr) 2000-12-22 2000-12-22 Utilisation de chelateurs pour le traitement des maladies a prions

Country Status (3)

Country Link
AU (1) AU2002216305A1 (fr)
FR (1) FR2818551B1 (fr)
WO (1) WO2002051415A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070037848A1 (en) * 2003-04-03 2007-02-15 Masters Colin L Treatment of neurological conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000516606A (ja) * 1996-08-13 2000-12-12 ピー・エヌ・ゲロリマトス・ソシエテ・アノニム アルツハイマー病の処置用医薬組成物の製造におけるキレート化剤クリオキノールの使用
EP1007040B1 (fr) * 1997-08-21 2002-05-08 P.N. Gerolymatos S.A. Utilisation de phanquinone dans le traitement de la maladie d'alzheimer
US5994323A (en) * 1997-12-31 1999-11-30 P.N. Gerolymatos S.A. Pharmaceutical compositions comprising clioquinol in combination with vitamin B12 and therapeutic and prophylactic uses thereof
US6323218B1 (en) * 1998-03-11 2001-11-27 The General Hospital Corporation Agents for use in the treatment of Alzheimer's disease

Also Published As

Publication number Publication date
FR2818551A1 (fr) 2002-06-28
WO2002051415A3 (fr) 2003-05-01
WO2002051415A2 (fr) 2002-07-04
AU2002216305A1 (en) 2002-07-08
WO2002051415B1 (fr) 2003-05-30

Similar Documents

Publication Publication Date Title
MA26992A1 (fr) Derives de phenethanolamine pour le traitement des maladies respiratoires
EP1178800A4 (fr) Traitement des maladies neurodegeneratives par des inhibiteurs de l'aspartyl protease
MA26951A1 (fr) Derives de pyrazole pour le traitement de maladies virales
MA27027A1 (fr) Inhibiteur de pde4 et agent anticholinergique en association pour le traitement de maladies obstructives des voies aeriennes
ATE345331T1 (de) Verbindungen verwendbar für die behandlung von entzündungskrankheiten
CH1143977H1 (fr) 2-Oxy-benzoxazine-4-ones destinees au traitement de l'obesite
NO20026008D0 (no) Fremgangsmåte for behandling av cardiovaskul¶re sykdommer
PT986308E (pt) Tratamento de carne por descarga de condensador
DE60105614D1 (de) Oxazinochinolone für die behandlung viraler infektionen
DE60134267D1 (de) Prophylaktische/therapeutische mittel für entzündliche atemwegserkrankungen
FR2800614B1 (fr) Composition pour le traitement des infections des voies respiratoires
FR2818551B1 (fr) Utilisation de chelateurs pour le traitement des maladies a prions
IL141950A0 (en) Diagnosis of prion diseases
PL373490A1 (en) Use of beta-adrenoceptor agonists for the treatment of neurodegenerative diseases
EP1172113A4 (fr) Remedes pour le traitement des neuropathies automatiques
MA25852A1 (fr) Methode pour le traitement de l'inflammation.
IL144949A0 (en) Treatment of prion diseases with dmso
FR2782007B1 (fr) Utilisation des calix(n)arenes pour le traitement des maladies fibrotiques
MA26908A1 (fr) S-methyl-dihydro-ziprasidone pour le traitement de troubles psychiatriques et oculaires
DK1200447T3 (da) Oxazinocarbazoler til behandling af CNS-sygdomme
FR2749151B1 (fr) Boite de tampons jetables pour nettoyage des chaussures
EP1304117A4 (fr) Remedes pour maladies osseuses
FR2824727B1 (fr) Orthese du pouce pour le traitement des entorses metacarpo-phalangiennes
FR2806293B1 (fr) Implants scleraux pour le traitement du decollement de retine
EP1161147A4 (fr) Mimetiques peptidiques utiles pour traiter des maladies

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20110831